L. Kabasakal Et Al. , "Pre-therapeutic dosimetry of normal organs and tissues of Lu-177-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer," EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.42, no.13, pp.1976-1983, 2015
Kabasakal, L. Et Al. 2015. Pre-therapeutic dosimetry of normal organs and tissues of Lu-177-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.42, no.13 , 1976-1983.
Kabasakal, L., AbuQbeitah, M., Aygun, A., Yeyin, N., Ocak, M., Demirci, E., ... Toklu, T.(2015). Pre-therapeutic dosimetry of normal organs and tissues of Lu-177-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.42, no.13, 1976-1983.
Kabasakal, Levent Et Al. "Pre-therapeutic dosimetry of normal organs and tissues of Lu-177-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer," EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.42, no.13, 1976-1983, 2015
Kabasakal, Levent Et Al. "Pre-therapeutic dosimetry of normal organs and tissues of Lu-177-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer." EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.42, no.13, pp.1976-1983, 2015
Kabasakal, L. Et Al. (2015) . "Pre-therapeutic dosimetry of normal organs and tissues of Lu-177-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer." EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.42, no.13, pp.1976-1983.
@article{article, author={Levent Kabasakal Et Al. }, title={Pre-therapeutic dosimetry of normal organs and tissues of Lu-177-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer}, journal={EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING}, year=2015, pages={1976-1983} }